Search Results

There are 8114 results for: content related to: Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs

  1. Intramuscular extended-release naltrexone: current evidence

    Annals of the New York Academy of Sciences

    Volume 1216, Issue 1, January 2011, Pages: 144–166, David R. Gastfriend

    Version of Record online : 27 JAN 2011, DOI: 10.1111/j.1749-6632.2010.05900.x

    Corrected by:

    Corrigendum for Ann. N. Y. Acad. Sci. 1216: 144–166

    Vol. 1224, Issue 1, 207, Version of Record online: 12 APR 2011

  2. Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals

    Alcoholism: Clinical and Experimental Research

    Volume 39, Issue 9, September 2015, Pages: 1832–1841, Dennis D. Rasmussen, Carrie L. Kincaid and Janice C. Froehlich

    Version of Record online : 11 AUG 2015, DOI: 10.1111/acer.12828

  3. Development of Naltrexone Supersensitivity During Food-Maintained Responding Enhances Naltrexone's Ability to Reduce Ethanol-Maintained Responding

    Alcoholism: Clinical and Experimental Research

    Volume 31, Issue 1, January 2007, Pages: 39–47, Keith L. Williams

    Version of Record online : 15 DEC 2006, DOI: 10.1111/j.1530-0277.2006.00272.x

  4. Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial

    Veterinary Ophthalmology

    Volume 18, Issue 6, November 2015, Pages: 497–501, Thomas Chen and Cynthia C. Powell

    Version of Record online : 10 FEB 2015, DOI: 10.1111/vop.12255

  5. Transdermal delivery of naltrexone and its active metabolite 6-β-naltrexol in human skin in vitro and guinea pigs in vivo

    Journal of Pharmaceutical Sciences

    Volume 94, Issue 9, September 2005, Pages: 1965–1975, Kalpana S. Paudel, Buchi N. Nalluri, Dana C. Hammell, Satyanarayana Valiveti, Paul Kiptoo, Mohamed O. Hamad, Peter A. Crooks and Audra L. Stinchcomb

    Version of Record online : 28 JUL 2005, DOI: 10.1002/jps.20398

  6. Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 8, August 2012, Pages: 2777–2786, Mikolaj Milewski, Raghotham R. Pinninti and Audra L. Stinchcomb

    Version of Record online : 24 MAY 2012, DOI: 10.1002/jps.23189

  7. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone

    Clinical & Experimental Ophthalmology

    Volume 42, Issue 2, March 2014, Pages: 159–168, Ian S Zagon, Joseph W Sassani, Jessica A Immonen and Patricia J McLaughlin

    Version of Record online : 29 JUL 2013, DOI: 10.1111/ceo.12144

  8. You have free access to this content
    Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid

    Cancer

    Volume 113, Issue 1, 1 July 2008, Pages: 193–201, Allan Lipton, Richard Cook, Fred Saad, Pierre Major, Patrick Garnero, Evangelos Terpos, Janet E. Brown and Robert E. Coleman

    Version of Record online : 5 MAY 2008, DOI: 10.1002/cncr.23529

  9. You have full text access to this OnlineOpen article
    A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders

    Annals of the New York Academy of Sciences

    Volume 1327, Issue 1, October 2014, Pages: 112–130, David R. Gastfriend

    Version of Record online : 18 SEP 2014, DOI: 10.1111/nyas.12538

  10. Specific and Nonspecific Effects of Naltrexone on Goal-Directed and Habitual Models of Alcohol Seeking and Drinking

    Alcoholism: Clinical and Experimental Research

    Volume 37, Issue 7, July 2013, Pages: 1100–1110, Rachel A. Hay, Joshua H. Jennings, Dawnya L. Zitzman, Clyde W. Hodge and Donita L. Robinson

    Version of Record online : 7 FEB 2013, DOI: 10.1111/acer.12081

  11. Combining Naltrexone and Prazosin in a Single Oral Medication Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone

    Alcoholism: Clinical and Experimental Research

    Volume 37, Issue 10, October 2013, Pages: 1763–1770, Janice C. Froehlich, Brett J. Hausauer and Dennis D. Rasmussen

    Version of Record online : 22 JUL 2013, DOI: 10.1111/acer.12148

  12. Interaction Between Family History of Alcoholism and Locus of Control in the Opioid Regulation of Impulsive Responding Under the Influence of Alcohol

    Alcoholism: Clinical and Experimental Research

    Volume 35, Issue 11, November 2011, Pages: 1905–1914, Lee J. Altamirano, Howard L. Fields, Mark D’Esposito and Charlotte A. Boettiger

    Version of Record online : 13 MAY 2011, DOI: 10.1111/j.1530-0277.2011.01535.x

  13. Moderators of Naltrexone’s Effects on Drinking, Urge, and Alcohol Effects in Non-Treatment-Seeking Heavy Drinkers in the Natural Environment

    Alcoholism: Clinical and Experimental Research

    Volume 32, Issue 1, January 2008, Pages: 58–66, Jennifer W. Tidey, Peter M. Monti, Damaris J. Rohsenow, Chad J. Gwaltney, Robert Miranda Jr., John E. McGeary, James MacKillop, Robert M. Swift, David B. Abrams, Saul Shiffman and Jean A. Paty

    Version of Record online : 20 NOV 2007, DOI: 10.1111/j.1530-0277.2007.00545.x

  14. Nontraditional crops, traditional constraints: The long-term welfare impacts of export crop adoption among Guatemalan smallholders

    Agricultural Economics

    Volume 42, Issue s1, November 2011, Pages: 61–76, Calogero Carletto, Talip Kilic and Angeli Kirk

    Version of Record online : 10 NOV 2011, DOI: 10.1111/j.1574-0862.2011.00552.x

  15. Alcohol Consumption Is Enhanced After Naltrexone Treatment

    Alcoholism: Clinical and Experimental Research

    Volume 31, Issue 2, February 2007, Pages: 260–264, Jorge Juárez and Barrios De Tomasi Eliana

    Version of Record online : 18 JAN 2007, DOI: 10.1111/j.1530-0277.2006.00313.x

  16. Effects of Naltrexone on Neural and Subjective Response to Alcohol in Treatment-Seeking Alcohol-Dependent Patients

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3024–3032, Primavera A. Spagnolo, Vijay A. Ramchandani, Melanie L. Schwandt, Lishu Zhang, Sara K. Blaine, Julie M. Usala, Kristie A. Diamond, Monte J. Phillips, David T. George, Reza Momenan and Markus Heilig

    Version of Record online : 7 JAN 2015, DOI: 10.1111/acer.12581

  17. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness

    Addiction

    Volume 108, Issue 9, September 2013, Pages: 1628–1637, Evgeny Krupitsky, Edward V. Nunes, Walter Ling, David R. Gastfriend, Asli Memisoglu and Bernard L. Silverman

    Version of Record online : 24 MAY 2013, DOI: 10.1111/add.12208

  18. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat

    Addiction Biology

    Volume 16, Issue 1, January 2011, Pages: 20–29, Jenny Häggkvist, Carl Björkholm, Pia Steensland, Sara Lindholm, Johan Franck and Björn Schilström

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1369-1600.2009.00199.x

  19. Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial

    Clinical Pharmacology & Therapeutics

    ME Mooney, JM Schmitz, S Allen, J Grabowski, P Pentel, A Oliver and DK Hatsukami

    Version of Record online : 20 JUN 2016, DOI: 10.1002/cpt.402

  20. Hepatic Safety of Once-Monthly Injectable Extended-Release Naltrexone Administered to Actively Drinking Alcoholics

    Alcoholism: Clinical and Experimental Research

    Volume 32, Issue 3, March 2008, Pages: 498–504, Michael R. Lucey, Bernard L. Silverman, Ari Illeperuma and Charles P. O’Brien

    Version of Record online : 30 JAN 2008, DOI: 10.1111/j.1530-0277.2007.00593.x